SFDA-2023-0037-V437
Type IB variation for application SFDA-2023-0037. Type IB variation: Shelf Life Extension for Thymosilib — minor update
Variation Number
SFDA-2023-0037-V437
Type
Type IB
Application
Change
Status
Pending
Fee
€3,156
Submitted
2023-07-11
Approved
—
Description
Type IB variation: Shelf Life Extension for Thymosilib — minor update